Masimo Corp Files 8-K on Financials
Ticker: MASI · Form: 8-K · Filed: Jul 9, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: MASI
TL;DR
MASI filed an 8-K on July 9th detailing financial results. Check it out.
AI Summary
Masimo Corporation filed an 8-K on July 9, 2024, to report on its results of operations and financial condition. The filing includes financial statements and exhibits related to the period ending July 9, 2024. Masimo Corp is incorporated in Delaware and headquartered in Irvine, California.
Why It Matters
This filing provides investors with updated financial information and operational results for Masimo Corporation, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that does not appear to contain any new material adverse events or significant changes.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- July 9, 2024 (date) — Date of Report
- 52 Discovery Irvine, CA 92618 (address) — Principal Executive Offices
- DE (jurisdiction) — State of incorporation
FAQ
What is the purpose of this 8-K filing for Masimo Corporation?
The purpose of this 8-K filing is to report on Masimo Corporation's results of operations and financial condition, including financial statements and exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on July 9, 2024.
Where is Masimo Corporation's principal executive office located?
Masimo Corporation's principal executive office is located at 52 Discovery, Irvine, CA 92618.
In which state is Masimo Corporation incorporated?
Masimo Corporation is incorporated in Delaware (DE).
What is the SIC code for Masimo Corporation?
The Standard Industrial Classification (SIC) code for Masimo Corporation is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 637 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-07-09 09:01:47
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value MASI The Nasdaq Stock Market
Filing Documents
- masi-20240709.htm (8-K) — 36KB
- masi-20240709xex991.htm (EX-99.1) — 74KB
- masi-q22024preearningspr.htm (EX-99.2) — 15KB
- masi-q22024preearningspr001.jpg (GRAPHIC) — 58KB
- masi-q22024preearningspr002.jpg (GRAPHIC) — 253KB
- masi-q22024preearningspr003.jpg (GRAPHIC) — 129KB
- masi-q22024preearningspr004.jpg (GRAPHIC) — 131KB
- masi-q22024preearningspr005.jpg (GRAPHIC) — 120KB
- masi-q22024preearningspr006.jpg (GRAPHIC) — 115KB
- masi-q22024preearningspr007.jpg (GRAPHIC) — 30KB
- masi-q22024preearningspr008.jpg (GRAPHIC) — 178KB
- masi-20240709_g1.jpg (GRAPHIC) — 199KB
- masimologoq2020.jpg (GRAPHIC) — 4KB
- 0000937556-24-000056.txt ( ) — 2112KB
- masi-20240709.xsd (EX-101.SCH) — 2KB
- masi-20240709_lab.xml (EX-101.LAB) — 22KB
- masi-20240709_pre.xml (EX-101.PRE) — 13KB
- masi-20240709_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On July 9, 2024, Masimo Corporation (the "Company") issued a press release announcing certain preliminary revenue and select financial results for the second quarter ended June 29, 2024 (the "Press Release") and provided a supplemental presentation to the Press Release (the "Presentation"). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and a copy of the Presentation is furnished as Exhibit 99.2 to this Current Report. The preliminary revenue and selected financial information presented in the Press Release and the Presentation is based on the Company's current expectations and may be adjusted as a result of, among other things, completion of customary quarter-end close review procedures and financial review. In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report, including Exhibits 99.1 and 99.2 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, Dated July 9, 2024, Reporting Preliminary Second Quarter 2024 Revenue and Select Financial Results 99.2 Masimo Prelimi n a ry S econd Quarter 20 2 4 Supplement al Pres entation to Press R elease 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MASIMO CORPORATION Date: July 9, 2024 By: /s/ M ICAH Y OUNG Micah Young Executive Vice President & Chief Financial Officer (Principal Financial Officer)